
Julie Elaine Burke
Examiner (ID: 11284)
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1806, 1642, 1813 |
| Total Applications | 297 |
| Issued Applications | 184 |
| Pending Applications | 71 |
| Abandoned Applications | 42 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4133582
[patent_doc_number] => 06015555
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-18
[patent_title] => 'Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates'
[patent_app_type] => 1
[patent_app_number] => 8/444644
[patent_app_country] => US
[patent_app_date] => 1995-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 77
[patent_figures_cnt] => 79
[patent_no_of_words] => 31245
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/015/06015555.pdf
[firstpage_image] =>[orig_patent_app_number] => 444644
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/444644 | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates | May 18, 1995 | Issued |
Array
(
[id] => 3657372
[patent_doc_number] => 05627073
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-06
[patent_title] => 'Hybridomas producing antibodies to cardiac hypertrophy factor'
[patent_app_type] => 1
[patent_app_number] => 8/443129
[patent_app_country] => US
[patent_app_date] => 1995-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 37047
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/627/05627073.pdf
[firstpage_image] =>[orig_patent_app_number] => 443129
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/443129 | Hybridomas producing antibodies to cardiac hypertrophy factor | May 16, 1995 | Issued |
Array
(
[id] => 3619179
[patent_doc_number] => 05614394
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-25
[patent_title] => 'Method and monoclonal antibodies for vitamin B12 determination'
[patent_app_type] => 1
[patent_app_number] => 8/442160
[patent_app_country] => US
[patent_app_date] => 1995-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4588
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/614/05614394.pdf
[firstpage_image] =>[orig_patent_app_number] => 442160
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/442160 | Method and monoclonal antibodies for vitamin B12 determination | May 15, 1995 | Issued |
Array
(
[id] => 4019986
[patent_doc_number] => 05907034
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-25
[patent_title] => 'Monoclonal antibody against complexed and non-complexed complexing agents for removing heavy metals from aqueous solutions and for analysis'
[patent_app_type] => 1
[patent_app_number] => 8/440354
[patent_app_country] => US
[patent_app_date] => 1995-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3131
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/907/05907034.pdf
[firstpage_image] =>[orig_patent_app_number] => 440354
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/440354 | Monoclonal antibody against complexed and non-complexed complexing agents for removing heavy metals from aqueous solutions and for analysis | May 11, 1995 | Issued |
Array
(
[id] => 4079966
[patent_doc_number] => 06054297
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-25
[patent_title] => 'Humanized antibodies and methods for making them'
[patent_app_type] => 1
[patent_app_number] => 8/437642
[patent_app_country] => US
[patent_app_date] => 1995-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 46015
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/054/06054297.pdf
[firstpage_image] =>[orig_patent_app_number] => 437642
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/437642 | Humanized antibodies and methods for making them | May 8, 1995 | Issued |
Array
(
[id] => 3546363
[patent_doc_number] => 05547668
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-20
[patent_title] => 'Conjugates of folate anti-effector cell antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/435175
[patent_app_country] => US
[patent_app_date] => 1995-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6233
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/547/05547668.pdf
[firstpage_image] =>[orig_patent_app_number] => 435175
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/435175 | Conjugates of folate anti-effector cell antibodies | May 4, 1995 | Issued |
Array
(
[id] => 3520188
[patent_doc_number] => 05506344
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-04-09
[patent_title] => 'Antibodies specific for BCL-2 gene product'
[patent_app_type] => 1
[patent_app_number] => 8/435193
[patent_app_country] => US
[patent_app_date] => 1995-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3499
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/506/05506344.pdf
[firstpage_image] =>[orig_patent_app_number] => 435193
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/435193 | Antibodies specific for BCL-2 gene product | May 4, 1995 | Issued |
| 08/431314 | METHODS AND PHARMACEUTICALS FOR MODELING AND TREATING ASTHMA | Apr 27, 1995 | Abandoned |
Array
(
[id] => 3622974
[patent_doc_number] => 05641870
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-24
[patent_title] => 'Low pH hydrophobic interaction chromatography for antibody purification'
[patent_app_type] => 1
[patent_app_number] => 8/425763
[patent_app_country] => US
[patent_app_date] => 1995-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 13185
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/641/05641870.pdf
[firstpage_image] =>[orig_patent_app_number] => 425763
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/425763 | Low pH hydrophobic interaction chromatography for antibody purification | Apr 19, 1995 | Issued |
Array
(
[id] => 3696892
[patent_doc_number] => 05645836
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-08
[patent_title] => 'Anti-AIDS immunotoxins'
[patent_app_type] => 1
[patent_app_number] => 8/422578
[patent_app_country] => US
[patent_app_date] => 1995-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 5734
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/645/05645836.pdf
[firstpage_image] =>[orig_patent_app_number] => 422578
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/422578 | Anti-AIDS immunotoxins | Apr 13, 1995 | Issued |
Array
(
[id] => 4098708
[patent_doc_number] => 06096871
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-01
[patent_title] => 'Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life'
[patent_app_type] => 1
[patent_app_number] => 8/422093
[patent_app_country] => US
[patent_app_date] => 1995-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 31323
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/096/06096871.pdf
[firstpage_image] =>[orig_patent_app_number] => 422093
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/422093 | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life | Apr 13, 1995 | Issued |
Array
(
[id] => 3730443
[patent_doc_number] => 05698203
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'European vaccine strains of the Porcine Reproductive Respiratory Syndrome virus (PRRSV)'
[patent_app_type] => 1
[patent_app_number] => 8/419781
[patent_app_country] => US
[patent_app_date] => 1995-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4831
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698203.pdf
[firstpage_image] =>[orig_patent_app_number] => 419781
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/419781 | European vaccine strains of the Porcine Reproductive Respiratory Syndrome virus (PRRSV) | Apr 10, 1995 | Issued |
Array
(
[id] => 3663364
[patent_doc_number] => 05656730
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-12
[patent_title] => 'Stabilized monomeric protein compositions'
[patent_app_type] => 1
[patent_app_number] => 8/417855
[patent_app_country] => US
[patent_app_date] => 1995-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5103
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/656/05656730.pdf
[firstpage_image] =>[orig_patent_app_number] => 417855
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/417855 | Stabilized monomeric protein compositions | Apr 6, 1995 | Issued |
Array
(
[id] => 3781378
[patent_doc_number] => 05821108
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'Enrichment for a thymocyte subset having progenitor cell activity using c-kit as a selection marker'
[patent_app_type] => 1
[patent_app_number] => 8/418534
[patent_app_country] => US
[patent_app_date] => 1995-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 10063
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821108.pdf
[firstpage_image] =>[orig_patent_app_number] => 418534
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/418534 | Enrichment for a thymocyte subset having progenitor cell activity using c-kit as a selection marker | Apr 6, 1995 | Issued |
| 08/418964 | ISOLATED FRPB NUCLEIC ACID MOLECULE AND VACCINE | Apr 6, 1995 | Abandoned |
Array
(
[id] => 3554271
[patent_doc_number] => 05543319
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-06
[patent_title] => 'Recombination-proficient avian/mammalian microcell hybrids'
[patent_app_type] => 1
[patent_app_number] => 8/415354
[patent_app_country] => US
[patent_app_date] => 1995-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8167
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/543/05543319.pdf
[firstpage_image] =>[orig_patent_app_number] => 415354
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/415354 | Recombination-proficient avian/mammalian microcell hybrids | Mar 30, 1995 | Issued |
Array
(
[id] => 3760762
[patent_doc_number] => 05843894
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Methods for reduced renal uptake of antibody fragments'
[patent_app_type] => 1
[patent_app_number] => 8/407899
[patent_app_country] => US
[patent_app_date] => 1995-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 7357
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843894.pdf
[firstpage_image] =>[orig_patent_app_number] => 407899
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/407899 | Methods for reduced renal uptake of antibody fragments | Mar 20, 1995 | Issued |
Array
(
[id] => 3729828
[patent_doc_number] => 05665552
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-09
[patent_title] => 'Antibodies to plasmodium falciparum'
[patent_app_type] => 1
[patent_app_number] => 8/408418
[patent_app_country] => US
[patent_app_date] => 1995-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5117
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/665/05665552.pdf
[firstpage_image] =>[orig_patent_app_number] => 408418
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/408418 | Antibodies to plasmodium falciparum | Mar 20, 1995 | Issued |
Array
(
[id] => 3786923
[patent_doc_number] => 05780030
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-14
[patent_title] => 'Passive vaccine against Lyme disease'
[patent_app_type] => 1
[patent_app_number] => 8/406623
[patent_app_country] => US
[patent_app_date] => 1995-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6480
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/780/05780030.pdf
[firstpage_image] =>[orig_patent_app_number] => 406623
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/406623 | Passive vaccine against Lyme disease | Mar 19, 1995 | Issued |
Array
(
[id] => 4144889
[patent_doc_number] => 06063621
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-16
[patent_title] => 'Antibodies to a multidrug resistance protein'
[patent_app_type] => 1
[patent_app_number] => 8/407207
[patent_app_country] => US
[patent_app_date] => 1995-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 23
[patent_no_of_words] => 33110
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/063/06063621.pdf
[firstpage_image] =>[orig_patent_app_number] => 407207
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/407207 | Antibodies to a multidrug resistance protein | Mar 19, 1995 | Issued |